These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18855997)

  • 21. [Relationship between expression of c-myc and p53 in liposarcoma].
    Wang YL; Qiu JS; Xiong M
    Ai Zheng; 2002 Jan; 21(1):63-7. PubMed ID: 12500400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Dedifferentiated liposarcoma. A clinico-pathologic study of 6 cases].
    Coindre JM; de Loynes B; Bui NB; Stockle E; de Mascarel I; Trojani M
    Ann Pathol; 1992; 12(1):20-8. PubMed ID: 1580936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishment of a novel human dedifferentiated liposarcoma cell line, FU-DDLS-1: conventional and molecular cytogenetic characterization.
    Nishio J; Iwasaki H; Ishiguro M; Ohjimi Y; Fujita C; Ikegami H; Ariyoshi A; Naito M; Kaneko Y; Kikuchi M
    Int J Oncol; 2003 Mar; 22(3):535-42. PubMed ID: 12579306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MDM2+/CDK4+/p53+ oral liposarcoma: case report and review of the literature.
    Nikitakis NG; Lopes MA; Pazoki AE; Ord RA; Sauk JJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):194-201. PubMed ID: 11505267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Retroperitoneal dedifferentiated liposarcoma with rhabdomyoblastic differentiation: a clinicopathological analysis].
    Liu L; Wang LH; Ren YB; Rao XS; Yang SM
    Zhonghua Bing Li Xue Za Zhi; 2018 Feb; 47(2):94-98. PubMed ID: 29429159
    [No Abstract]   [Full Text] [Related]  

  • 26. Primary dedifferentiated Liposarcoma of vagina: a first case report.
    Xie C; Shen Y
    Diagn Pathol; 2021 Jan; 16(1):3. PubMed ID: 33422117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary cardiac dedifferentiated liposarcoma with homologous and heterologous differentiation: a case report.
    He D; Chen M; Chen H; Liao D; Wang X; Zhang Z; Zhang H
    Int J Clin Exp Pathol; 2015; 8(8):9662-6. PubMed ID: 26464734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic alteration of p16INK4a gene in dedifferentiation of liposarcoma.
    He M; Aisner S; Benevenia J; Patterson F; Harrison LE; Hameed M
    Pathol Res Pract; 2009; 205(6):386-94. PubMed ID: 19186005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alterations of the RB1 gene in dedifferentiated liposarcoma.
    Takahira T; Oda Y; Tamiya S; Yamamoto H; Kobayashi C; Izumi T; Ito K; Iwamoto Y; Tsuneyoshi M
    Mod Pathol; 2005 Nov; 18(11):1461-70. PubMed ID: 15933756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dedifferentiated liposarcoma composed predominantly of rhabdoid/epithelioid cells: a frequently misdiagnosed highly aggressive variant.
    Agaimy A; Michal M; Hadravsky L; Michal M
    Hum Pathol; 2018 Jul; 77():20-27. PubMed ID: 29307627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dedifferentiated liposarcoma with inflammatory myofibroblastic tumor-like features.
    Lucas DR; Shukla A; Thomas DG; Patel RM; Kubat AJ; McHugh JB
    Am J Surg Pathol; 2010 Jun; 34(6):844-51. PubMed ID: 20431481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Whole blood miRNA expression analysis reveals miR-3613-3p as a potential biomarker for dedifferentiated liposarcoma.
    Fricke A; Cimniak AFV; Ullrich PV; Becherer C; Bickert C; Pfeifer D; Heinz J; Stark GB; Bannasch H; Braig D; Eisenhardt SU
    Cancer Biomark; 2018; 22(2):199-207. PubMed ID: 29689704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dedifferentiated Liposarcoma: Updates on Morphology, Genetics, and Therapeutic Strategies.
    Thway K; Jones RL; Noujaim J; Zaidi S; Miah AB; Fisher C
    Adv Anat Pathol; 2016 Jan; 23(1):30-40. PubMed ID: 26645460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dedifferentiated Liposarcoma of Sigmoid Mesocolon - A Case Report.
    Constantinoiu S; Achim IF; Cretu OE; Dumitru T; Constantin A; Enache S; Mates IN;
    Chirurgia (Bucur); 2016; 111(4):330-6. PubMed ID: 27604671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on liposarcoma: a review for cytopathologists.
    Dodd LG
    Diagn Cytopathol; 2012 Dec; 40(12):1122-31. PubMed ID: 21932353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dedifferentiated liposarcoma of the spermatic cord with a hemangioendothelioma-like component: a case report and review of the literature.
    Okano S; Yamamoto H; Kono S; Fujii H; Shirabe K; Maehara Y; Oda Y
    Pathol Res Pract; 2013 Sep; 209(9):596-604. PubMed ID: 23910173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct mdm2/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms.
    Pilotti S; Della Torre G; Lavarino C; Di Palma S; Sozzi G; Minoletti F; Rao S; Pasquini G; Azzarelli A; Rilke F; Pierotti MA
    J Pathol; 1997 Jan; 181(1):14-24. PubMed ID: 9071998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study.
    Ray-Coquard I; Blay JY; Italiano A; Le Cesne A; Penel N; Zhi J; Heil F; Rueger R; Graves B; Ding M; Geho D; Middleton SA; Vassilev LT; Nichols GL; Bui BN
    Lancet Oncol; 2012 Nov; 13(11):1133-40. PubMed ID: 23084521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Well-differentiated liposarcoma and dedifferentiated liposarcoma: An updated review.
    Thway K
    Semin Diagn Pathol; 2019 Mar; 36(2):112-121. PubMed ID: 30852045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dedifferentiated liposarcoma of the pyriform sinus: report of a case and review of the literature.
    González-Lois C; Ibarrola C; Ballestín C; Martánez-Tello FJ
    Int J Surg Pathol; 2002 Jan; 10(1):75-9. PubMed ID: 11927975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.